Predictive role of magnetic resonance imaging in the distinction of isocitrate dehydrogenase (IDH) mutant grade 4 astrocytomas versus glioblastomas
Acta Radiologica · 2023
DOI: 10.1177/02841851231165282 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Radiologica, 2023. Verfasst von Ahmet Mesrur Halefoglu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Sisli Hamidiye Etfal Training and Research Hospital, University of Health Sciences, Istanbul,Turkey. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioblastoma, Glioma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Background
Isocitrate dehydrogenase (IDH) mutation status is a crucial prognostic factor in high-grade glial tumors.
Purpose
To investigate whether magnetic resonance imaging (MRI) features can display a diagnostic performance in the determination of IDH mutation in high-grade gliomas. Material and Methods A total of 170 patients including 24 IDH mutant grade 4 astrocytomas and 146 glioblastomas (GBM) were retrospectively examined via contrast-enhanced (CE) MRI before surgery. Immunohistochemistry and genomic sequence analyses were performed on specimen materials for the determination of IDH mutational status. Certain morphological and diffusion-weighted imaging (DWI) parameters were utilized to see if they could play a role to be non-invasive potential imaging predictors in the discrimination of IDH mutant versus wild-type (WT) high-grade gliomas.
Results
On histopathological examination, IDH mutation was detected in 24 patients with high-grade glioma and 146 of the patients were found to be WT. Certain morphological criteria of tumor location and involvement, tumor margins, visual detection of diffusion restriction on DWI, and quantitative apparent diffusion coefficient (ADC) parameters consisting of ADC mean , ADC min , and ADC r could be used as imaging predictors in the discrimination of high-grade IDH mutant versus WT tumors.
Conclusion
Certain MRI morphologic features and visual detection of diffusion restriction on DWI and quantitative ADC parameters consisting of ADC mean , ADC min , and ADC r can be considered non-invasive, significant independent imaging predictors in the discrimination and can obviate invasive procedures for histopathological diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sisli Hamidiye Etfal Training and Research Hospital, University of Health Sciences, Istanbul,Turkey.
- Department of Radiology, Sisli Etfal Training and Research Hospital, Istanbul, Turkey.
- Department of Pathology, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Sisli, Turkey.
- Department of Radiation Oncology, Sisli Etfal Training and Research Hospital, Istanbul, Turkey.
- Department of Neurosurgery, Sisli Etfal Training and Research Hospital, Istanbul, Turkey.
ORCID-Profile: Ahmet Mesrur Halefoglu
Zitieren
APA
Halefoglu, A. M., Camurcuoglu, E., Tanik, C., Kizilkaya, O., & Yilmaz, A. (2023). Predictive role of magnetic resonance imaging in the distinction of isocitrate dehydrogenase (IDH) mutant grade 4 astrocytomas versus glioblastomas. Acta Radiologica. https://doi.org/10.1177/02841851231165282
Vancouver
Halefoglu AM, Camurcuoglu E, Tanik C, Kizilkaya O, Yilmaz A. Predictive role of magnetic resonance imaging in the distinction of isocitrate dehydrogenase (IDH) mutant grade 4 astrocytomas versus glioblastomas. Acta Radiologica. 2023. doi:10.1177/02841851231165282
BibTeX
@article{Halefoglu2023,
author = {Halefoglu, Ahmet Mesrur and Camurcuoglu, Eyup and Tanik, Canan and Kizilkaya, Orhan and Yilmaz, Adem},
title = {Predictive role of magnetic resonance imaging in the distinction of isocitrate dehydrogenase (IDH) mutant grade 4 astrocytomas versus glioblastomas},
journal = {Acta Radiologica},
year = {2023},
doi = {10.1177/02841851231165282}
}
EUVIMED